Login / Signup
Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study.
Ioannis I Spiliotis
Rod Chalk
Stephen Gough
Patrik Rorsman
Published in:
Diabetes, obesity & metabolism (2022)
Keyphrases
</>
low dose
type diabetes
high dose
glycemic control
cardiovascular disease
insulin resistance
skeletal muscle
adipose tissue